Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moulin

Showing results (161-170 of 188) with videos related to

Pageof 19
Sort By:
Atherosclerosis|June 11, 2026
Systematic evaluation of mobile element insertions in autosomal dominant hypercholesterolemia genes using short-read sequencingLisa Jeanpetit, Corentin Molitor, Alexandre Janin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 17, 2022
A new 165-SNP low-density lipoprotein cholesterol polygenic risk score based on next generation sequencing outperforms previously published scores in routine diagnostics of familial hypercholesterolemiaXavier Vanhoye, Claire Bardel, Antoine Rimbert, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Diabetes Care|January 31, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter StudyCyrielle Caussy, Bruno Vergès, Damien Leleu, et al.
Atherosclerosis|June 1, 2022
The spoils of war and the long-term spoiling of health conditions of entire nationsEliano P Navarese, Klaudyna Grzelakowska, Francesco Mangini, et al.
The Journal of Pediatrics|September 1, 2022
Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic DiagnosisNoel Peretti, Alexandre Vimont, Emmanuel Mas, et al.
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Clinical Genetics|October 28, 2020
Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemiaOriane Marmontel, Pierre Antoine Rollat-Farnier, Anne-Sophie Wozny, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2020
Phenotypic Differences Between Polygenic and Monogenic HypobetalipoproteinemiaAntoine Rimbert, Xavier Vanhoye, Dramane Coulibaly, et al.
Nature Genetics|May 6, 2003
Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaMarianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, et al.
Pageof 19

Showing results (161-170 of 188) with videos related to

Sort By:
Pageof 19
Atherosclerosis|June 11, 2026
Systematic evaluation of mobile element insertions in autosomal dominant hypercholesterolemia genes using short-read sequencingLisa Jeanpetit, Corentin Molitor, Alexandre Janin, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 17, 2022
A new 165-SNP low-density lipoprotein cholesterol polygenic risk score based on next generation sequencing outperforms previously published scores in routine diagnostics of familial hypercholesterolemiaXavier Vanhoye, Claire Bardel, Antoine Rimbert, et al.
Atherosclerosis|March 6, 2024
Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS)Bilal Bashir, See Kwok, Anthony S Wierzbicki, et al.
Diabetes Care|January 31, 2025
Screening for Metabolic Dysfunction-Associated Steatotic Liver Disease-Related Advanced Fibrosis in Diabetology: A Prospective Multicenter StudyCyrielle Caussy, Bruno Vergès, Damien Leleu, et al.
Atherosclerosis|June 1, 2022
The spoils of war and the long-term spoiling of health conditions of entire nationsEliano P Navarese, Klaudyna Grzelakowska, Francesco Mangini, et al.
The Journal of Pediatrics|September 1, 2022
Factors Predicting Statin Initiation During Childhood in Familial Hypercholesterolemia: Importance of Genetic DiagnosisNoel Peretti, Alexandre Vimont, Emmanuel Mas, et al.
Archives of Cardiovascular Diseases|November 29, 2021
Lipoprotein(a): Pathophysiology, measurement, indication and treatment in cardiovascular disease. A consensus statement from the Nouvelle Société Francophone d'Athérosclérose (NSFA)Vincent Durlach, Dominique Bonnefont-Rousselot, Franck Boccara, et al.
Clinical Genetics|October 28, 2020
Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemiaOriane Marmontel, Pierre Antoine Rollat-Farnier, Anne-Sophie Wozny, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 19, 2020
Phenotypic Differences Between Polygenic and Monogenic HypobetalipoproteinemiaAntoine Rimbert, Xavier Vanhoye, Dramane Coulibaly, et al.
Nature Genetics|May 6, 2003
Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaMarianne Abifadel, Mathilde Varret, Jean-Pierre Rabès, et al.
Pageof 19